Zobrazeno 1 - 10
of 13
pro vyhledávání: '"E. K. Havrdova"'
Autor:
M. Lefort, S. Sharmin, J. B. Andersen, S. Vukusic, R. Casey, M. Debouverie, G. Edan, J. Ciron, A. Ruet, J. De Sèze, E. Maillart, H. Zephir, P. Labauge, G. Defer, C. Lebrun-Frenay, T. Moreau, E. Berger, P. Clavelou, J. Pelletier, B. Stankoff, O. Gout, E. Thouvenot, O. Heinzlef, A. Al-Khedr, B. Bourre, O. Casez, P. Cabre, A. Montcuquet, A. Wahab, J. P. Camdessanché, A. Maurousset, H. Ben Nasr, K. Hankiewicz, C. Pottier, N. Maubeuge, D. Dimitri-Boulos, C. Nifle, D. A. Laplaud, D. Horakova, E. K. Havrdova, R. Alroughani, G. Izquierdo, S. Eichau, S. Ozakbas, F. Patti, M. Onofrj, A. Lugaresi, M. Terzi, P. Grammond, F. Grand’Maison, B. Yamout, A. Prat, M. Girard, P. Duquette, C. Boz, M. Trojano, P. McCombe, M. Slee, J. Lechner-Scott, R. Turkoglu, P. Sola, D. Ferraro, F. Granella, V. Shaygannejad, J. Prevost, D. Maimone, O. Skibina, K. Buzzard, A. Van der Walt, R. Karabudak, B. Van Wijmeersch, T. Csepany, D. Spitaleri, S. Vucic, N. Koch-Henriksen, F. Sellebjerg, P. S. Soerensen, C. C. Hilt Christensen, P. V. Rasmussen, M. B. Jensen, J. L. Frederiksen, S. Bramow, H. K. Mathiesen, K. I. Schreiber, H. Butzkueven, M. Magyari, T. Kalincik, E. Leray
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Natalizumab and fingolimod are used as high-efficacy treatments in relapsing–remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control t
Externí odkaz:
https://doaj.org/article/84c3797631444a10b4fb616e78d4bf21
Autor:
Katherine Buzzard, Dana Horáková, Guillermo Izquierdo, P. Grammond, S. Ozakbas, Francesco Patti, C. Boz, Tomas Kalincik, Francois Grand'Maison, Gilles Edan, E. K. Havrdova, Izanne Roos, Charles B Malpas, Ofsep Study Groups, Helmut Butzkueven, Jeannette Lechner-Scott, Jonathan Ciron, Sandra Vukusic, Emmanuelle Leray, Jean Pelletier, Sara Eichau Madueno, Oliver Gerlach, Pierre Clavelou, Olga Skibina, Marc Debouverie, Romain Casey, Maria Pia Amato
Publikováno v:
Neurology
Neurology, American Academy of Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
Neurology, American Academy of Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
ObjectiveTo compare the clinical effectiveness of high- and low-efficacy treatments in patients with recently active and inactive secondary progressive multiple sclerosis (SPMS) after accounting for therapeutic lag.MethodsPatients treated with high-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e92a18c1b372a4f4f2026f28b50f47d
https://hal.archives-ouvertes.fr/hal-03282036
https://hal.archives-ouvertes.fr/hal-03282036
Autor:
S. Vieira Alves Leon, Luke Chung, G. Comi, H.-P. Hartung, Pamela A. McCombe, E. K. Havrdova, C. Pozzilli, Jihad Inshasi, K. Selmaj, Salman Afsar, Kunio Nakamura, Celia Oreja-Guevara, Daniel Pelletier, Thomas F. Scott, Douglas L. Arnold, A N Boyko, Xavier Montalban, Nadia Daizadeh
Publikováno v:
Multiple Sclerosis Journal. 25:131-356
Introduction: In CARE-MS II (NCT00548405), alemtuzumab (12mg/day; baseline: 5 days; 12 months later: 3 days) significantly improved clinical/MRI outcomes vs SC IFNB-1a over 2 years (y) in RRMS patients with inadequate response to prior therapy. Effic
Autor:
Jan Krasensky, Manuela Vaneckova, E. K. Havrdova, Balazs Lorincz, Dana Horáková, Tomas Uher, Ranjani Ganapathy Subramanian
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 2230, p 2230 (2021)
Diagnostics; Volume 11; Issue 12; Pages: 2230
Diagnostics, Vol 11, Iss 2230, p 2230 (2021)
Diagnostics; Volume 11; Issue 12; Pages: 2230
Background: There is a lack of knowledge about the evolution of cerebrospinal fluid (CSF) markers in multiple sclerosis (MS) patients undergoing natalizumab treatment. Aim: We aimed to evaluate the effect of natalizumab on basic inflammatory CSF and
Autor:
Tomas Kalincik, Marc Girard, Neil J Scolding, Thor Petersen, Julie Prevost, Guillermo Izquierdo, Tjalf Ziemssen, Owen R Pearson, N. Deri, Dana Horakova, Pierre Grammond, Eugenio Pucci, R. Alroughani, Patrizia Sola, Alastair Wilkins, B. Van Wijmeersch, François Grand'Maison, Vahid Shaygannejad, Pierre Duquette, Alexandre Prat, Michael Hutchinson, Jeannette Lechner-Scott, Roberto Bergamaschi, J. W. L. Brown, Aysun Soysal, Maria Trojano, Franco Granella, E. K. Havrdova, Murat Terzi, Michael L. Barnett, D. Spitaleri, Alasdair Coles, Diana Ferraro, Radek Ampapa, Vilija Jokubaitis, N. Robsertson, Katharine Harding, Pamela A. McCombe, Claudio Solaro, G. Iuliano, Fraser Moore, Christopher McGuigan, Vincent Van Pesch, R. Hupperts, Alessandra Lugaresi, Helmut Butzkueven, Jose Luis Sanchez-Menoyo, Claire M Rice, C. Ramo-Tello, Tim Spelman
Publikováno v:
Multiple Sclerosis Journal. 23:8-84
Autor:
Diana Ferraro, J. W. L. Brown, C. Ramo-Tello, Cameron Shaw, Mark Slee, Tomas Kalincik, Marc Girard, Xavier Ayrignac, Helmut Butzkueven, Jeannette Lechner-Scott, Julie Prevost, Roberto Bergamaschi, Alexandre Prat, D. Spitaleri, Pierre Grammond, Aysun Soysal, Myintzu Min, François Grand'Maison, Eugenio Pucci, Dana Horakova, Talal Al-Harbi, E. K. Havrdova, Maria Trojano, Franco Granella, G. De Luca, Giuseppe Iuliano, Alessandra Lugaresi, Pamela A. McCombe, A. Perez Sempere, C. Boz, Neil Shuey, Vincent Van Pesch, S. Ozakbas, Jose Luis Sanchez-Menoyo, Fraser Moore, Elena Tsantes, Vilija Jokubaitis, Tünde Csépány, R. Hupperts, M. Edite Rio, Patrizia Sola, B. Van Wijmeersch, Erica Curti, Guillermo Izquierdo, Pierre Duquette, Michael Hutchinson, Murat Terzi, R. Alroughani, Y. Sidhom
Publikováno v:
Multiple Sclerosis Journal. 23:976-1023
Autor:
Michael G. Dwyer, Tomas Uher, Robert Zivadinov, E. K. Havrdova, Tomas Kalincik, Niels Bergsland, Charles B Malpas, Dana Horáková, Jan Krasensky, Manuela Vaneckova
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
article-version (Version of Record) 3
ObjectiveTo describe the dynamics of brain volume loss (BVL) at different stages of relapsing-remitting multiple sclerosis (RRMS), to describe the association between BVL and clinical measures, and to investigate an effect of treatment escalation on
Autor:
Carlo Pozzilli, E. K. Havrdova, Carlos Navas, Sara Eichau, Simon Broadley, Barry A Singer, Raed Alroughani, Ho Jin Kim, H.-P. Hartung, Alex Rovira, Kunio Nakamura
Publikováno v:
Multiple Sclerosis and Related Disorders. 26:258
Autor:
Kunio Nakamura, A N Boyko, E. K. Havrdova, Celia Oreja-Guevara, Daniel Pelletier, Jihad Inshasi, Carlo Pozzilli, H.-P. Hartung, Pamela A. McCombe, Douglas L. Arnold, G. Comi
Publikováno v:
Multiple Sclerosis and Related Disorders. 26:258
Autor:
David Margolin, Edward Fox, Stephen Lake, Pedro Oyuela, Gavin Giovannoni, J. A. Cohen, E. K. Havrdova, Michael Panzara, Christian Confavreux, Alasdair Coles, Alastair Compston, Vesna V. Brinar, Douglas L. Arnold, Krzysztof Selmaj, H.-P. Hartung, Miroslav Stojanovic, Howard L. Weiner
Publikováno v:
Neurology. 78:S41.006-S41.006